Works matching Hand-foot syndrome

Results: 1477

Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinoma.

Published in:

2016

By:

Lai, Jin‐Shei;
Beaumont, Jennifer L.;
Diaz, Jose;
Khan, Sadya;
Cella, David;
Lai, Jin-Shei

Publication type:

journal article

The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.

Published in:

Australasian Journal of Dermatology, 2016, v. 57, n. 1, p. e14, doi. 10.1111/ajd.12224

By:

Li, Zhiming;
Jiang, Nanyan;
Xu, Yunsheng

Publication type:

Article

The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 6, p. 953, doi. 10.1007/s00432-010-0958-9

By:

Zhang, Rong-Xin;
Wu, Xiao-Jun;
Lu, Shi-Xun;
Pan, Zhi-Zhong;
Wan, De-Sen;
Chen, Gong

Publication type:

Article

Impact of comprehensive nursing on hand-foot syndrome caused by oral capecitabine in breast cancer patients.

Published in:

African Journal of Reproductive Health, 2024, v. 28, n. 9, p. 163, doi. 10.29063/ajrh2024/v28i9.15

By:

Shanshan He;
Mi Wang;
Liuliu Zhang;
Ping Zhu;
Jianmei Zhou;
Zhiping Fang;
Lingyun Shi

Publication type:

Article

Incidence and severity of hand-foot syndrome in cancer patients receiving infusional 5-fluorouracil or oral capecitabine-containing chemotherapy regimens.

Published in:

Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 2, p. 203, doi. 10.1177/10781552241228175

By:

Abdul Kareem, Sulaikha;
Joseph, Simi Grace;
Wilson, Aneena;
Kareem, Shahnaz Abdul;
Kunjumon Vilapurathu, Jobin

Publication type:

Article

Chemotherapeutic metabolism presenting as a recalcitrant case of hand–foot syndrome and mucositis.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 584, doi. 10.1177/10781552241226595

By:

Kwan, Kevin R;
Skokan, Shayna;
Blesh-Boren, Tara;
Vogel, Jenilee;
Harter, Nicole;
Ford, James B

Publication type:

Article

Hand-foot syndrome and nail disorders secondary to treatment with paclitaxel: Is there a relationship with the presence of fungi?

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 8, p. 1798, doi. 10.1177/10781552211043752

By:

Pereira, Paulina Patente;
Nunes Filho, Mário;
Moreira, Tomaz de Aquino;
Duarte Silva Malvino, Lucivânia;
de Araújo, Lúcio Borges;
dos Santos Pedroso, Reginaldo;
Ângela Ribeiro, Maria

Publication type:

Article

How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 919, doi. 10.1177/10781552211009291

By:

Chen, Jiexiu;
Wang, Zhuo

Publication type:

Article

Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 3, p. 190, doi. 10.1177/1078155217693426

By:

Bailey, Erin B.;
Merriman, Joseph;
Maughan, Benjamin;
Poole, Austin;
Tantravahi, Srinivas K.;
Agarwal, Archana M.;
Batten, Julia A.;
Patel, Shiven B.;
Pal, Sumanta K.;
Stenehjem, David D.;
Agarwal, Neeraj

Publication type:

Article

卡培他滨相关基因多态性与手足综合征关系的研究进展.

Published in:

Practical Oncology Journal, 2018, v. 32, n. 2, p. 149, doi. 10.11904/j.issn.1002-3070.2018.02.012

By:

李响;
刘铎;
吴东媛;
范晓凡;
张娟;
董梅

Publication type:

Article

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach.

Published in:

Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 435, doi. 10.1007/s00280-020-04128-7

By:

Schmulenson, Eduard;
Krolop, Linda;
Simons, Sven;
Ringsdorf, Susanne;
Ko, Yon-Dschun;
Jaehde, Ulrich

Publication type:

Article

SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome.

Published in:

2020

By:

Liao, Xin;
Huang, Liu;
Yu, Qianqian;
He, Siyuan;
Li, Qianxia;
Huang, Chao;
Yuan, Xianglin

Publication type:

journal article

Management of cytotoxic chemotherapy-induced hand-foot syndrome.

Published in:

Oncology Reviews, 2020, v. 14, n. 1, p. 57, doi. 10.4081/oncol.2020.442

By:

Kwakman, Johannes J. M.;
Elshot, Yannick S.;
Punt, Cornelis J. A.;
Koopman, Miriam

Publication type:

Article

玉肤解毒膏治疗结直肠癌患者卡培他滨化疗所致手足综合征的疗效观察.

Published in:

Progress in Modern Biomedicine, 2023, v. 23, n. 7, p. 1274, doi. 10.13241/j.cnki.pmb.2023.07.014

By:

李宁;
王莹雪;
刘赳;
梁慧

Publication type:

Article

Sunitinib-induced hand-foot syndrome in a Kashmiri male.

Published in:

2014

By:

Mir, Mohammad H.;
Rather, Parvaiz A.;
Bagdadi, Farhana

Publication type:

Case Study

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth.

Published in:

Cancer Management & Research, 2018, v. 10, p. 805, doi. 10.2147/CMAR.S159370

By:

Kamimura, Kenya;
Shinagawa-Kobayashi, Yoko;
Goto, Ryo;
Ogawa, Kohei;
Yokoo, Takeshi;
Sakamaki, Akira;
Abe, Satoshi;
Kamimura, Hiroteru;
Suda, Takeshi;
Baba, Hiroshi;
Tanaka, Takayuki;
Nozawa, Yoshizu;
Koyama, Naoto;
Takamura, Masaaki;
Kawai, Hirokazu;
Yamagiwa, Satoshi;
Aoyagi, Yutaka;
Terai, Shuji

Publication type:

Article

Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report.

Published in:

BMC Endocrine Disorders, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1472-6823-14-26

By:

Velandia Carrillo, Carlos A.;
Wandurraga Sanchez, Edwin A.;
Gomez Abreo, Diego A.

Publication type:

Article

Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters.

Published in:

2021

By:

Liang, Guohua;
Ma, Wenjie;
Zhao, Yanfang;
Liu, Eryu;
Shan, Xiaoyu;
Ma, Weiwei;
Tang, Dabei;
Li, Liru;
Niu, Xingjian;
Zhao, Wenhui;
Zhang, Qingyuan

Publication type:

journal article

Evaluation of hand-foot syndrome and hand-foot skin reaction: Case series.

Published in:

Turkish Archives of Dermatology & Venerology / Turkderm, 2019, v. 53, n. 1, p. 28, doi. 10.4274/turkderm.galenos.2018.98624

By:

Demirdağ, Hatice Gamze;
Ayanoğlu, Burcu Tuğrul;
Armağan, Başak Yalıcı

Publication type:

Article

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).

Published in:

2022

By:

Santhosh, Akhil;
Kumar, Akash;
Pramanik, Raja;
Gogia, Ajay;
Prasad, Chandra Prakash;
Gupta, Ishaan;
Gupta, Nishkarsh;
Cheung, Winson Y.;
Pandey, Ravindra Mohan;
Sharma, Atul;
Batra, Atul

Publication type:

journal article

High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study.

Published in:

BMC Pharmacology & Toxicology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s40360-021-00529-3

By:

Zhao, Yanfang;
Su, Wenjia;
Liang, Guohua;
Shan, Xiaoyu;
Ma, Weiwei;
Tang, Dabei;
Li, Liru;
Niu, Xingjian;
Zhao, Shu;
Zhang, Qingyuan;
Zhao, Wenhui

Publication type:

Article

Analysis of risk factors in breast cancer patients with hand-foot syndrome and oral mucositis caused by pegylated liposomal doxorubicin.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1564681

By:

Quan, Xianghua;
Li, Jing;
Sun, Jialin;
Xing, Xiaomin;
Liu, Donghua;
Ji, Hongyan;
Guo, Qie

Publication type:

Article

Identification of metabolites associated with capecitabine-induced hand-foot syndrome using untargeted metabolomics in patients with cancer.

Published in:

Molecular Medicine Reports, 2025, v. 32, n. 1, p. N.PAG, doi. 10.3892/mmr.2025.13568

By:

Bai, Yuru;
Chen, Hong;
Gu, Leying;
Shi, Bo;
Wang, Zhen;
Duanmu, Yuanyuan;
Hu, Ying;
Wang, Yu;
Zhang, Chaoyi;
Su, Zhaotian

Publication type:

Article

Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report.

Published in:

2014

By:

MASAFUMI INOKUCHI;
SATOKO ISHIKAWA;
HIROYUKI FURUKAWA;
HIROYUKI TAKAMURA;
ITASU NINOMIYA;
HIROHISA KITAGAWA;
SACHIO FUSHIDA;
TAKASHI FUJIMURA;
TETSUO OHTA

Publication type:

Case Study

Capecitabine-induced hand-foot syndrome does not emerge in the complex regional pain syndrome-affected limb: A case report.

Published in:

Molecular & Clinical Oncology, 2021, v. 15, n. 6, p. N.PAG, doi. 10.3892/mco.2021.2416

By:

Inoue, Reo;
Abe, Hiroaki;
Konishi, Mitsuru;
Tsuchida, Rikuhei;
Edamura, Tatsuma;
Sumitani, Masahiko

Publication type:

Article

7p15 deletion as the cause of hand-foot-genital syndrome: a case report, literature review and proposal of a minimum region for this phenotype.

Published in:

2017

By:

Yokoyama, Emiy;
Smith-Pellegrin, Dennise Lesley;
Sánchez, Silvia;
Molina, Bertha;
Rodríguez, Alfredo;
Juárez, Rocío;
Lieberman, Esther;
Avila, Silvia;
Castrillo, José Luis;
del Castillo, Victoria;
Frías, Sara

Publication type:

Case Study

Reconstruction of bilateral tibial aplasia and split hand-foot syndrome in a father and daughter.

Published in:

2014

By:

Al Kaissi, Ali;
Ganger, Rudolf;
Klaushofer, Klaus;
Grill, Franz

Publication type:

Case Study

A systematic review and Meta-analysis on the association between Hand-Foot Syndrome (HFS) and Cancer Chemotherapy Efficacy.

Published in:

Clinica Terapeutica, 2019, v. 170, n. 5, p. e388, doi. 10.7417/CT.2019.2165

By:

Falcone, G.;
Arrigoni, C.;
Dellafiore, F.;
Gallucci, F.;
Milani, V.;
Boveri, S.;
Ausili, D.;
Caruso, R.

Publication type:

Article

Evaluation of Oral Nano-Silymarin Formulation Efficacy in the Prevention of Hand-Foot Syndrome and Neuropathy Induced by XELOX or m-FOLFOX6 Regimens in Metastatic Colorectal Cancer: A Triple-Blinded, Randomized Clinical Trial.

Published in:

IJ Pharmaceutical Research (IJPR), 2024, v. 23, n. 1, p. 1, doi. 10.5812/ijpr-152364

By:

Karbasforooshan, Hedyieh;
Rahimi, Hossein;
Arasteh, Omid;
Allahyari, Abolghasem;
Varmaghani, Mehdi;
Jannati, Mahdi;
Ghavami, Vahid;
Jaafari, Mahmoodreza;
Elyasi, Sepideh

Publication type:

Article

Capecitabine Associated Hand-Foot Syndrome: A Review.

Published in:

Clinical Medicine Reviews in Oncology, 2010, n. 2, p. 133

By:

Cidón, Esther Uña

Publication type:

Article

A Double-Blind, Randomized Trial of Pyridoxine Versus Placebo for the Prevention of Pegylated Liposomal Doxorubicin-Related Hand-Foot Syndrome in Gynecologic Oncology Patients.

Published in:

Cancer (0008543X), 2010, v. 116, n. 20, p. 4735, doi. 10.1002/cncr.25262

By:

Von Gruenigen, Vivian;
Frasure, Heidi;
Fusco, Nancy;
DeBernardo, Robert;
Eldermire, Elisa;
Eaton, Susan;
Waggoner, Steven

Publication type:

Article

Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).

Published in:

2022

By:

Iimura, Yohei;
Furukawa, Naoki;
Ishibashi, Masaaki;
Ahiko, Yuka;
Tanabe, Taro;
Aikou, Susumu;
Shida, Dai;
Nojima, Masanori;
Kuroda, Seiichiro;
Boku, Narikazu

Publication type:

journal article

Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13684-1

By:

Wongkraisri, Concord;
Chusuwanrak, Kriengkrai;
Laocharoenkeat, Apirom;
Chularojanamontri, Leena;
Nimmannit, Akarin;
Ithimakin, Suthinee

Publication type:

Article

Nursing care of severe hand foot syndrome caused by the oral anti-tumour drug Xeloda: a case study.

Published in:

World Council of Enterostomal Therapists Journal, 2022, v. 42, n. 1, p. 29, doi. 10.33235/wcet.42.1.29-33

By:

Shuangshuang Zhang;
Wenxing Zhao;
Mengmeng Zhang

Publication type:

Article

Risk Factors of Capecitabine-Induced Hand-Foot Syndrome: A Single-Institution, Retrospective Study.

Published in:

Oncology, 2023, v. 101, n. 7, p. 407, doi. 10.1159/000529851

By:

Kanbayashi, Yuko;
Taguchi, Tetsuya;
Ishikawa, Takeshi;
Otsuji, Eigo;
Takayama, Koichi

Publication type:

Article

Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study.

Published in:

Oncology, 2017, v. 93, p. 113, doi. 10.1159/000481241

By:

Ogawa, Chikara;
Morita, Masahiro;
Omura, akina;
Noda, Teruyo;
Kubo, atsushi;
Matsunaka, Toshihiro;
Tamaki, Hiroyuki;
Shibatoge, Mitsushige;
Tsutsui, akemi;
Senoh, Tomonori;
Nagano, Takuya;
Takaguchi, Kouichi;
Tani, Joji;
Morishita, asahiro;
Yoneyama, Hirohito;
Masaki, Tsutomu;
Moriya, akio;
ando, Masaharu;
Deguchi, akihiro;
Kokudo, Yasutaka

Publication type:

Article

Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand-foot syndrome: A meta-analysis.

Published in:

Biomedical Reports, 2013, v. 1, n. 6, p. 873, doi. 10.3892/br.2013.161

By:

YUN ZHOU;
LING PENG;
YINGIE LI;
LIXUN CHEN

Publication type:

Article

Paraneoplastic Bullous Pemphigoid Masquerading as Hand-foot Syndrome: A Case Report of Rare Entity.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2020, v. 16, n. Supp9, p. 127

By:

Mohan, Subhatharshni;
Rahim, Nazatul Shima Abdul;
Salleh, Amizatul Aini;
Mahayidin, Hasni;
Bakrin, Ikmal Hisyam

Publication type:

Article

The Efficacy and Safety of Captopril in Preventing Capecitabine-induced Hand-foot Syndrome: A Randomized Double-blinded Placebo-controlled Clinical Trial.

Published in:

Middle East Journal of Cancer, 2023, v. 14, n. 2, p. 292, doi. 10.30476/mejc.2022.93268.1680

By:

Roayaei, Mahnaz;
Nazeminezhad, Nooshin;
Najafizade, Nadia;
Sharifi, Mehran

Publication type:

Article

A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 4, p. 479, doi. 10.1007/s00280-022-04411-9

By:

Abuhelwa, Ahmad Y.;
Badaoui, Sarah;
Yuen, Hoi-Yee;
McKinnon, Ross A.;
Ruanglertboon, Warit;
Shankaran, Kiran;
Tuteja, Anniepreet;
Sorich, Michael J.;
Hopkins, Ashley M.

Publication type:

Article

Efficacy of topical Lawsonia inermis L. (Henna) hydrogel in fluorouracil-induced hand-foot syndrome: a pilot randomized double-blind placebo-controlled clinical trial.

Published in:

Cutaneous & Ocular Toxicology, 2021, v. 40, n. 3, p. 257, doi. 10.1080/15569527.2021.1940194

By:

Mohajerani, Razieh;
Shahi, Farhad;
Jafariazar, Zahra;
Afshar, Minoo

Publication type:

Article

Topical henna ameliorated capecitabine-induced hand-foot syndrome.

Published in:

Cutaneous & Ocular Toxicology, 2014, v. 33, n. 3, p. 253, doi. 10.3109/15569527.2013.832280

By:

Ilyas, Saher;
Wasif, Komal;
Saif, Muhammad Wasif

Publication type:

Article

Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study.

Published in:

Integrative Cancer Therapies, 2022, v. 21, p. 1, doi. 10.1177/15347354221140402

By:

Xiaozhe, Li;
Meilan, Chen;
Beihui, Huang;
Junru, Liu;
Jingli, Gu;
Lifen, Kuang;
Juan, Li

Publication type:

Article

Effect of Chinese Herbal Compound LC09 on Patients With Capecitabine-Associated Hand-Foot Syndrome: A Randomized, Double-Blind, and Parallel-Controlled Trial.

Published in:

Integrative Cancer Therapies, 2020, v. 19, p. 1, doi. 10.1177/1534735420928466

By:

Yu, Ran;
Wu, Xuefeng;
Jia, Liqun;
Lou, Yanni

Publication type:

Article

Hemoglobin Value Is the Most Important Factor in the Development of Hand-Foot Syndrome under the Capecitabine Regimen.

Published in:

Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 23, doi. 10.1159/000445866

By:

Naito, Masahito;
Yamamoto, Tomoya;
Hara, Shinsuke;
Shimamoto, Chikao;
Miwa, Yoshihiro

Publication type:

Article

Spermine-Related DNA Hypermethylation and Elevated Expression of Genes for Collagen Formation are Susceptible Factors for Chemotherapy-Induced Hand-Foot Syndrome in Chinese Colorectal Cancer Patients.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.746910

By:

Li, Mingming;
Chen, Jiani;
Liu, Shaoqun;
Sun, Xiaomeng;
Xu, Huilin;
Gao, Qianmin;
Chen, Xintao;
Xi, Chaowen;
Huang, Doudou;
Deng, Yi;
Zhang, Feng;
Gao, Shouhong;
Qiu, Shi;
Tao, Xia;
Zhai, Jingwen;
Wei, Hua;
Yao, Houshan;
Chen, Wansheng

Publication type:

Article

Pharmacological prevention strategy for capecitabine‐induced hand‐foot syndrome: A network meta‐analysis of randomized control trials.

Published in:

Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15774

By:

Kao, Yung‐Shuo;
Lo, Chen‐Hsu;
Tu, Yu‐Kang;
Hung, Cheng‐Hsien

Publication type:

Article

Apatinib‐induced Grade 3 hand‐foot syndrome in advanced lung adenocarcinoma successful treated with thalidomide: A case report.

Published in:

Dermatologic Therapy, 2020, v. 33, n. 2, p. 1, doi. 10.1111/dth.13241

By:

Ren, Yue;
Li, Ting;
Du, Lei‐Ya;
Qiu, Ye;
Wang, Shan‐Bing;
Lei, Kai‐Jian;
Jia, Yu‐Ming

Publication type:

Article

Hand-foot syndrome caused by capecitabine: incidence, risk factors and the role of dermatological evaluation.

Published in:

Ecancermedicalscience, 2022, v. 16, n. 1366-1414, p. 1, doi. 10.3332/ecancer.2022.1390

By:

Rodrigues de Queiroz, Marina Vieira;
Tardin Rodrigues de Medeiros, Ana Carolina;
Toledo, Sarah Pires;
de Abreu Sarmenghi, Karina Demoner;
Fiorin de Vasconcellos, Vitor

Publication type:

Article

Thymidine phosphorylase as a molecular target for quercetin-incorporated collagen matrix in the prevention of hand–foot syndrome induced by capecitabine in rats.

Published in:

Canadian Journal of Physiology & Pharmacology, 2023, v. 101, n. 7, p. 340, doi. 10.1139/cjpp-2022-0439

By:

Mashaly, Maryam E.;
Kotb, Hams M.;
Abdin, Amany A.;
Hedya, Sabiha E.

Publication type:

Article